Numerous studies have confirmed that polydatin application could suppress phospholipase A2 (PLA2) against lipopolysaccharide (LPS)-induced lung injury [54], decreasing the serum levels of alanine transaminase (ALT) and aspartate aminotransferase (AST) against fulminant hepatic failure (FHF) [55]. This evidence concerns the gene GPT and Fulminant hepatic failure.